Your browser doesn't support javascript.
loading
Influence of pre-existing invasive aspergillosis on allo-HSCT outcome: a retrospective EBMT analysis by the Infectious Diseases and Acute Leukemia Working Parties.
Penack, O; Tridello, G; Hoek, J; Socié, G; Blaise, D; Passweg, J; Chevallier, P; Craddock, C; Milpied, N; Veelken, H; Maertens, J; Ljungman, P; Cornelissen, J; Thiebaut-Bertrand, A; Lioure, B; Michallet, M; Iacobelli, S; Nagler, A; Mohty, M; Cesaro, S.
Afiliação
  • Penack O; Department of Hematology, Oncology and Tumorimmunology, Charité University Medicine Berlin, Campus Virchow Klinikum, Allogeneic Stem Cell Transplantation Service, Berlin, Germany.
  • Tridello G; Department of Paediatric Hematology and Oncology, Policlinico GB Rossi, Verona, Italy.
  • Hoek J; EBMT Data Office, Leiden, The Netherlands.
  • Socié G; Service d'Hématologie Greffe, Hopital St Louis, Paris, France.
  • Blaise D; Unité de Transplantation et de Thérapie Cellulaire, Institut Paoli Calmettes, Marseille, France.
  • Passweg J; Department of Hematology, University Hospital, Basel, Switzerland.
  • Chevallier P; Department of Hematology, CHU Nantes, Nantes, France.
  • Craddock C; BMT Unit, Queen Elizabeth Hospital, Birmingham, UK.
  • Milpied N; Hématologie Clinique et thérapie cellulaire, CHU Bordeaux, Pessac, France.
  • Veelken H; Department of Hematology, Leiden University Hospital, Leiden, The Netherlands.
  • Maertens J; Department of Hematology, University Hospital Gasthuisberg, Leuven, Belgium.
  • Ljungman P; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.
  • Cornelissen J; Department of Hematology, Erasmus MC-Daniel den Hoed Cancer Centre, Rotterdam, The Netherlands.
  • Thiebaut-Bertrand A; Clinique d'hématologie, Hopital A Michallon, Grenoble, France.
  • Lioure B; Department of Onco-Hematology, Nouvel Hopital Civil, Strasbourg, France.
  • Michallet M; Department of Hematology, Centre Hospitalier Lyon Sud, Lyon, France.
  • Iacobelli S; Centro Interdipartimentale di Biostatistica e Bioinformatica, Università Tor Vergata, Rome, Italy.
  • Nagler A; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Aviv University, Tel-Hashomer, Israel.
  • Mohty M; Service d'Hématologie Clinique et de Thérapie Cellulaire, Hospital Saint Antoine, Paris, France.
  • Cesaro S; Department of Paediatric Hematology and Oncology, Policlinico GB Rossi, Verona, Italy.
Bone Marrow Transplant ; 51(3): 418-23, 2016 Mar.
Article em En | MEDLINE | ID: mdl-26501769
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles / 7_ODS3_muertes_prevenibles_nacidos_ninos Base de dados: MEDLINE Assunto principal: Aspergilose / Leucemia / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Revista: Bone Marrow Transplant Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles / 7_ODS3_muertes_prevenibles_nacidos_ninos Base de dados: MEDLINE Assunto principal: Aspergilose / Leucemia / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Revista: Bone Marrow Transplant Ano de publicação: 2016 Tipo de documento: Article